Abstract: | In the course of the development work, natural and synthetic polymers were examined to see whether they were suitable for use as plasma substitutes. The criteria of a plasma substitute are discussed in this connection. The most important of the base substances used at present (dextran, modified gelatin, polyvinylpyrrolidone, and hydroxyethyl starch) are described, and a typical example of proven therapeutic value is discussed for each type. |